These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2540995)

  • 21. Morphine-naloxone interactions: a role for nonspecific morphine excitatory effects in withdrawal.
    Stevens DR; Klemm WR
    Science; 1979 Sep; 205(4413):1379-8. PubMed ID: 224462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of buprenorphine/naloxone in opioid-dependent patients: an Italian observational study.
    Magnelli F; Biondi L; Calabria R; Fiore A; Peluso E; Vonella D; Rota AG
    Clin Drug Investig; 2010; 30 Suppl 1():21-6. PubMed ID: 20450242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for an endorphin dysfunction in methadone addicts: lack of ACTH response to naloxone.
    Gold MS; Pottash AL; Extein I; Martin DA; Finn LB; Sweeney DR; Kleber HD
    Drug Alcohol Depend; 1981 Nov; 8(3):257-62. PubMed ID: 6276118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dependence on tetrahydrocannabinol in rhesus monkeys.
    Beardsley PM; Balster RL; Harris LS
    J Pharmacol Exp Ther; 1986 Nov; 239(2):311-9. PubMed ID: 3021952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opiate dependence and withdrawal--a new synthesis?
    Hendrie CA
    Pharmacol Biochem Behav; 1985 Nov; 23(5):863-70. PubMed ID: 3001782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
    Rehni AK; Singh I; Singh N; Bansal N; Bansal S; Kumar M
    Eur J Pharmacol; 2008 Nov; 598(1-3):51-6. PubMed ID: 18840427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions.
    Eissenberg T; Stitzer ML; Bigelow GE; Buchhalter AR; Walsh SL
    J Pharmacol Exp Ther; 1999 May; 289(2):936-45. PubMed ID: 10215673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Precipitated withdrawal by pentazocine in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1993 Nov; 267(2):624-34. PubMed ID: 7504098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys.
    Su RB; Lu XQ; Huang Y; Liu Y; Gong ZH; Wei XL; Wu N; Li J
    Eur J Pharmacol; 2008 Jun; 587(1-3):155-62. PubMed ID: 18455724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naltrexone precipitated opiate withdrawal in methadone addicted human subjects: evidence for noradrenergic hyperactivity.
    Charney DS; Redmond DE; Galloway MP; Kleber HD; Heninger GR; Murberg M; Roth RH
    Life Sci; 1984 Sep; 35(12):1263-72. PubMed ID: 6482651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is withdrawal hyperalgesia in morphine-dependent mice a direct effect of a low concentration of the residual drug?
    Rubovitch V; Pick CG; Sarne Y
    Addict Biol; 2009 Sep; 14(4):438-46. PubMed ID: 19489750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1995 Feb; 272(2):628-38. PubMed ID: 7853176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys.
    Aceto MD; Flora RE; Harris LS
    Pharmacology; 1977; 15(1):1-9. PubMed ID: 402658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opiate withdrawal.
    Farrell M
    Addiction; 1994 Nov; 89(11):1471-5. PubMed ID: 7841858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous naloxone administration suppresses opiate withdrawal symptoms in human opiate addicts during detoxification treatment.
    Loimer N; Schmid RW; Presslich O; Lenz K
    J Psychiatr Res; 1989; 23(1):81-6. PubMed ID: 2547057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT).
    Krystal JH; Woods SW; Kosten TR; Rosen MI; Seibyl JP; van Dyck CC; Price LH; Zubal IG; Hoffer PB; Charney DS
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):47-63. PubMed ID: 7762544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute effects of buprenorphine, hydromorphone and naloxone in methadone-maintained volunteers.
    Strain EC; Preston KL; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1992 Jun; 261(3):985-93. PubMed ID: 1376362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.